ArticleFrontiers in pharmacology2017

Tetradecyl 2,3-Dihydroxybenzoate Improves the Symptoms of Diabetic Mice by Modulation of Insulin and Adiponectin Signaling Pathways.

Lan Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.